Format

Send to

Choose Destination
See comment in PubMed Commons below
Surg Oncol Clin N Am. 2011 Apr;20(2):273-9, vii-viii. doi: 10.1016/j.soc.2010.11.002. Epub 2010 Dec 13.

Radiofrequency ablation of neuroendocrine hepatic metastasis.

Author information

  • 1Medical College of Wisconsin, Division of Surgical Oncology, 9200 West Wisconsin Avenue, Milwaukee, WI 53226-3596, USA. tcgamblin@mcw.edu

Abstract

Neuroendocrine cancer commonly metastasizes to the liver and often presents as unresectable disease. Liver resection or debulking most of the tumor provides a survival advantage for patients. Whether used alone or in combination with resection, radiofrequency ablation provides a unique tool to destroy metastases to the liver and spare hepatic parenchyma. Although randomized trials are lacking, retrospective series provide promising data to consider radiofrequency ablation in the management of hepatic neuroendocrine metastases.

PMID:
21377583
DOI:
10.1016/j.soc.2010.11.002
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center